• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中老年中国人非酒精性脂肪性肝病的脂肪肝指数验证

Validation of the Fatty Liver Index for Nonalcoholic Fatty Liver Disease in Middle-Aged and Elderly Chinese.

作者信息

Huang Xiaolin, Xu Min, Chen Ying, Peng Kui, Huang Ya, Wang Po, Ding Lin, Lin Lin, Xu Yu, Chen Yuhong, Lu Jieli, Wang Weiqing, Bi Yufang, Ning Guang

机构信息

From the State Key Laboratory of Medical Genomics, Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health, National Clinical Research Center for Metabolic Diseases, Collaborative Innovation Center of Systems Biomedicine and Shanghai Clinical Center for Endocrine and Metabolic Diseases (XH, MX, YC, KP, YH, PW, LD, LL, YX, YC, JL, WW, YB, GN); and Shanghai Institute of Endocrine and Metabolic Diseases, Department of Endocrine and Metabolic Diseases, Rui-Jin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China (XH, MX, YC, KP, YH, PW, LD, LL, YX, YC, JL, WW, YB, GN).

出版信息

Medicine (Baltimore). 2015 Oct;94(40):e1682. doi: 10.1097/MD.0000000000001682.

DOI:10.1097/MD.0000000000001682
PMID:26448014
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4616754/
Abstract

The fatty liver index (FLI), which is an algorithm based on waist circumference, body mass index (BMI), triglyceride, and gamma-glutamyl-transferase (GGT), was initially developed to detect fatty liver in Western countries. Our study aimed to evaluate the accuracy and optimal cut-off point of the FLI for predicting nonalcoholic fatty liver disease (NAFLD) in middle-aged and elderly Chinese. This cross-sectional study included 8626 Chinese adults aged 40 years or above recruited from Jiading District, Shanghai, China. Anthropometric and biochemical features were collected by a standard protocol. NAFLD was diagnosed by hepatic ultrasonography. The accuracy and cut-off point of the FLI to detect NAFLD were evaluated by area under the receiver operator characteristic curve (AUROC) and the maximum Youden index analysis, respectively. The AUROC of the FLI for NAFLD was 0.834 (95% confidence interval: 0.825-0.842), and larger than that of its each individual component [0.786 (0.776-0.796), 0.783 (0.773-0.793), 0.727 (0.716-0.739), and 0.707 (0.695-0.719) for waist circumference, BMI, triglyceride, and GGT, respectively] (all P < 0.001). The optimal cut-off point of the FLI for diagnosing NAFLD was 30 with the maximum Youden Index of 0.51, achieving a high sensitivity of 79.89% and a specificity of 71.51%. The FLI-diagnosed NAFLD individuals were in worse metabolic characteristics (waist circumference, BMI, blood pressure, serum lipids, and aminotransferases) than ultrasonography-diagnosed NAFLD patients (all P < 0.05).The FLI could accurately identify NAFLD and the optimal cut-off point was 30 in middle-aged and elderly Chinese. As FLI-diagnosed NAFLD patients were in worse metabolism, much attention should be paid to the metabolic controls and managements of NAFLD.

摘要

脂肪肝指数(FLI)是一种基于腰围、体重指数(BMI)、甘油三酯和γ-谷氨酰转移酶(GGT)的算法,最初是为在西方国家检测脂肪肝而开发的。我们的研究旨在评估FLI预测中国中老年非酒精性脂肪性肝病(NAFLD)的准确性和最佳切点。这项横断面研究纳入了从中国上海嘉定区招募的8626名40岁及以上的中国成年人。通过标准方案收集人体测量和生化特征。通过肝脏超声诊断NAFLD。分别通过受试者操作特征曲线下面积(AUROC)和最大约登指数分析评估FLI检测NAFLD的准确性和切点。FLI诊断NAFLD的AUROC为0.834(95%置信区间:0.825 - 0.842),大于其各个单独成分的AUROC[腰围、BMI、甘油三酯和GGT的AUROC分别为0.786(0.776 - 0.796)、0.783(0.773 - 0.793)、0.727(0.716 - 0.739)和0.707(0.695 - 0.719)](所有P < 0.001)。FLI诊断NAFLD的最佳切点为30,最大约登指数为(0.51),灵敏度为(79.89%),特异性为(71.51%)。FLI诊断为NAFLD的个体在代谢特征(腰围、BMI、血压、血脂和转氨酶)方面比超声诊断的NAFLD患者更差(所有P < 0.05)。FLI可以准确识别中国中老年人群中的NAFLD,最佳切点为30。由于FLI诊断的NAFLD患者代谢更差,应高度重视NAFLD的代谢控制和管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2358/4616754/82c30982ee7f/medi-94-e1682-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2358/4616754/82c30982ee7f/medi-94-e1682-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2358/4616754/82c30982ee7f/medi-94-e1682-g002.jpg

相似文献

1
Validation of the Fatty Liver Index for Nonalcoholic Fatty Liver Disease in Middle-Aged and Elderly Chinese.中老年中国人非酒精性脂肪性肝病的脂肪肝指数验证
Medicine (Baltimore). 2015 Oct;94(40):e1682. doi: 10.1097/MD.0000000000001682.
2
A community-based study on the application of fatty liver index in screening subjects with nonalcoholic fatty liver disease.一项基于社区的研究,探讨脂肪肝指数在筛查非酒精性脂肪肝疾病患者中的应用。
J Formos Med Assoc. 2020 Jan;119(1 Pt 1):173-181. doi: 10.1016/j.jfma.2019.03.016. Epub 2019 Apr 11.
3
Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease.预测非酒精性脂肪性肝病的脂肪肝指数与腰围对比
World J Gastroenterol. 2016 Mar 14;22(10):3023-30. doi: 10.3748/wjg.v22.i10.3023.
4
External validation of the fatty liver index for identifying nonalcoholic fatty liver disease in a population-based study.基于人群的研究中评估脂肪肝指数识别非酒精性脂肪肝的外部验证。
Clin Gastroenterol Hepatol. 2013 Sep;11(9):1201-4. doi: 10.1016/j.cgh.2012.12.031. Epub 2013 Jan 22.
5
Validation of fatty liver index and hepatic steatosis index for screening of non-alcoholic fatty liver disease in adults with obstructive sleep apnea hypopnea syndrome.验证脂肪肝指数和肝脂肪变性指数在阻塞性睡眠呼吸暂停低通气综合征成人非酒精性脂肪肝疾病筛查中的应用。
Chin Med J (Engl). 2019 Nov 20;132(22):2670-2676. doi: 10.1097/CM9.0000000000000503.
6
Role of Fatty Liver Index and Metabolic Factors in the Prediction of Nonalcoholic Fatty Liver Disease in a Lean Population Receiving Health Checkup.脂肪肝指数和代谢因素在体检瘦人群体中非酒精性脂肪肝预测中的作用。
Clin Transl Gastroenterol. 2019 May 22;10(5):1-8. doi: 10.14309/ctg.0000000000000042.
7
The accuracy of fatty liver index for the screening of overweight and obese children for non-alcoholic fatty liver disease in resource limited settings.在资源有限的环境中,脂肪肝指数对超重和肥胖儿童非酒精性脂肪肝的筛查准确性。
BMC Pediatr. 2022 Aug 30;22(1):511. doi: 10.1186/s12887-022-03575-w.
8
Validation of the Fatty Liver Index for identifying non-alcoholic fatty liver disease in a Kenyan population.验证脂肪肝指数在肯尼亚人群中识别非酒精性脂肪性肝病的价值。
Trop Med Int Health. 2023 Oct;28(10):830-838. doi: 10.1111/tmi.13927. Epub 2023 Aug 31.
9
Prevalence, clinical characteristics, risk factors, and indicators for lean Chinese adults with nonalcoholic fatty liver disease.非酒精性脂肪性肝病瘦型中国成年人的患病率、临床特征、危险因素和指标。
World J Gastroenterol. 2020 Apr 21;26(15):1792-1804. doi: 10.3748/wjg.v26.i15.1792.
10
Validation of simple indexes for nonalcoholic fatty liver disease in western China: a retrospective cross-sectional study.中国西部非酒精性脂肪性肝病简易指标的验证:一项回顾性横断面研究
Endocr J. 2018 Mar 28;65(3):373-381. doi: 10.1507/endocrj.EJ17-0466. Epub 2018 Mar 9.

引用本文的文献

1
Association between cholecystectomy and the risk of new-onset metabolic dysfunction-associated steatotic liver disease: a risk-stratified cohort study.胆囊切除术与新发代谢功能障碍相关脂肪性肝病风险之间的关联:一项风险分层队列研究。
Sci Rep. 2025 Aug 2;15(1):28223. doi: 10.1038/s41598-025-13556-5.
2
Potential utility of the fatty liver index as a predictor of erectile dysfunction and its severity.脂肪肝指数作为勃起功能障碍及其严重程度预测指标的潜在效用。
BMC Urol. 2025 Jul 25;25(1):183. doi: 10.1186/s12894-025-01865-w.
3
Combined impact of prediabetes and fatty liver index on cardiometabolic outcomes and mortality in middle aged adults: a nationwide cohort study.

本文引用的文献

1
Biomarkers in nonalcoholic fatty liver disease.非酒精性脂肪性肝病的生物标志物。
Can J Gastroenterol Hepatol. 2014 Dec;28(11):607-18. doi: 10.1155/2014/757929.
2
Fatty liver disease index: a simple screening tool to facilitate diagnosis of nonalcoholic fatty liver disease in the Chinese population.脂肪肝疾病指数:一种简便的筛查工具,有助于诊断中国人群的非酒精性脂肪性肝病。
Dig Dis Sci. 2013 Nov;58(11):3326-34. doi: 10.1007/s10620-013-2774-y. Epub 2013 Jul 31.
3
Low serum potassium level is associated with nonalcoholic fatty liver disease and its related metabolic disorders.
中年成年人中糖尿病前期与脂肪肝指数对心脏代谢结局和死亡率的联合影响:一项全国性队列研究
Cardiovasc Diabetol. 2025 Jul 10;24(1):279. doi: 10.1186/s12933-025-02793-7.
4
Hyperuricemia-Especially "Metabolic Hyperuricemia"-Is Independently Associated with a Higher Risk of Steatotic Liver Disease.高尿酸血症——尤其是“代谢性高尿酸血症”——与脂肪性肝病的较高风险独立相关。
Metabolites. 2025 May 28;15(6):356. doi: 10.3390/metabo15060356.
5
Impact of steatotic liver diseases on diabetes mellitus risk in patients with atrial fibrillation: a nationwide population study.脂肪性肝病对心房颤动患者糖尿病风险的影响:一项全国性人群研究。
Cardiovasc Diabetol. 2025 Jun 7;24(1):242. doi: 10.1186/s12933-025-02795-5.
6
Assessment of the diagnostic efficacy of five non-invasive tests for MASLD: external validation utilizing data from two cohorts.评估五种非侵入性检测方法对代谢相关脂肪性肝病(MASLD)的诊断效能:利用两个队列的数据进行外部验证
Front Nutr. 2025 May 22;12:1571487. doi: 10.3389/fnut.2025.1571487. eCollection 2025.
7
Predicting metabolic dysfunction associated steatotic liver disease using explainable machine learning methods.使用可解释的机器学习方法预测代谢功能障碍相关脂肪性肝病
Sci Rep. 2025 Apr 11;15(1):12382. doi: 10.1038/s41598-025-96478-6.
8
HEPNET Position Statement-I, Case Definition, Classification, Screening & Diagnosis of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Pakistan: A Resource for Primary and Secondary Care Physicians.巴基斯坦肝脏网络立场声明 - I,代谢功能障碍相关脂肪性肝病(MASLD)的病例定义、分类、筛查与诊断:基层和二级医疗医生资源
Pak J Med Sci. 2025 Mar;41(3):929-938. doi: 10.12669/pjms.41.3.10081.
9
Impact of remnant cholesterol on acute ischemic stroke prognosis: a nationwide cohort analysis stratified by non-alcoholic fatty liver disease status.残余胆固醇对急性缺血性卒中预后的影响:一项按非酒精性脂肪性肝病状态分层的全国性队列分析。
Front Neurol. 2025 Jan 30;16:1472871. doi: 10.3389/fneur.2025.1472871. eCollection 2025.
10
Big Data Research for Diabetes-Related Diseases Using the Korean National Health Information Database.利用韩国国家健康信息数据库开展糖尿病相关疾病的大数据研究。
Diabetes Metab J. 2025 Jan;49(1):13-21. doi: 10.4093/dmj.2024.0780. Epub 2025 Jan 1.
血清钾水平低与非酒精性脂肪性肝病及其相关代谢紊乱有关。
Clin Endocrinol (Oxf). 2014 Mar;80(3):348-55. doi: 10.1111/cen.12168. Epub 2013 May 20.
4
External validation of the fatty liver index for identifying nonalcoholic fatty liver disease in a population-based study.基于人群的研究中评估脂肪肝指数识别非酒精性脂肪肝的外部验证。
Clin Gastroenterol Hepatol. 2013 Sep;11(9):1201-4. doi: 10.1016/j.cgh.2012.12.031. Epub 2013 Jan 22.
5
Review article: the diagnosis of non-alcoholic fatty liver disease -- availability and accuracy of non-invasive methods.综述文章:非酒精性脂肪性肝病的诊断——非侵入性方法的可用性和准确性。
Aliment Pharmacol Ther. 2013 Feb;37(4):392-400. doi: 10.1111/apt.12186. Epub 2012 Dec 20.
6
Nonalcoholic fatty liver disease is associated with atherosclerosis in middle-aged and elderly Chinese.非酒精性脂肪性肝病与中老年中国人的动脉粥样硬化有关。
Arterioscler Thromb Vasc Biol. 2012 Sep;32(9):2321-6. doi: 10.1161/ATVBAHA.112.252957. Epub 2012 Jul 19.
7
Validation of fatty liver index and lipid accumulation product for predicting fatty liver in Korean population.韩国人群中用于预测脂肪肝的脂肪肝指数和脂质蓄积产物的验证
Liver Int. 2011 Nov;31(10):1600-1. doi: 10.1111/j.1478-3231.2011.02580.x. Epub 2011 Jul 5.
8
Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults.系统评价:成人非酒精性脂肪性肝病和非酒精性脂肪性肝炎的流行病学和自然史。
Aliment Pharmacol Ther. 2011 Aug;34(3):274-85. doi: 10.1111/j.1365-2036.2011.04724.x. Epub 2011 May 30.
9
Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease.非酒精性脂肪性肝病患者的心血管疾病风险
N Engl J Med. 2010 Sep 30;363(14):1341-50. doi: 10.1056/NEJMra0912063.
10
Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.利用超声和肝活检对以中老年人为主的人群进行非酒精性脂肪性肝病和非酒精性脂肪性肝炎的患病率:一项前瞻性研究。
Gastroenterology. 2011 Jan;140(1):124-31. doi: 10.1053/j.gastro.2010.09.038. Epub 2010 Sep 19.